Meckler Jeffrey Ainsider trades
In SEC Form 4 filings, Meckler Jeffrey A is listed as Director of Travere Therapeutics, Inc. (TVTX). In the last 90 days, Meckler Jeffrey A sold $1.35M of Travere Therapeutics, Inc. (TVTX) on the open market and bought none. All 4 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | Director | 8 | Sep 11 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-11
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | Sep 10 | Sep 11 | M | 10,000 | $17.44 | $174,400 | 101,500 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 10 | Sep 11 | M | 10,000 | $26.52 | $265,200 | 111,500 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 10 | Sep 11 | S | 1,700 | $65.39 | Sale −$111,166 | 109,800 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 10 | Sep 11 | S | 1,200 | $66.15 | Sale −$79,380 | 108,600 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 10 | Sep 11 | S | 14,000 | $67.46 | Sale −$944,488 | 94,600 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 10 | Sep 11 | S | 3,100 | $68.09 | Sale −$211,073 | 91,500 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 10 | Sep 11 | M · derivative | 10,000 | $17.44 | $174,400 | not reported | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 10 | Sep 11 | M · derivative | 10,000 | $26.52 | $265,200 | not reported | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.